(Q44548623)

4 December 2017

title

Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity (English)

1 reference

4 December 2017

main subject

Acanthamoeba keratitis

1 reference

inferred from title

author name string

Juan J Pérez-Santonja

1

1 reference

4 December 2017

Simon Kilvington

2

1 reference

4 December 2017

Reanne Hughes

3

1 reference

4 December 2017

Adnan Tufail

4

1 reference

4 December 2017

Melville Matheson

5

1 reference

4 December 2017

John K G Dart

6

1 reference

4 December 2017

publication date

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

110

1 reference

4 December 2017

issue

8

1 reference

4 December 2017

page(s)

1593-1600

1 reference

Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Persistence of acanthamoeba antigen following acanthamoeba keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Strategies for the management of microbial keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Acanthamoeba keratitis: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Use of Corticosteroids in Combination with Antimicrobial Drugs in the Treatment of Infectious Corneal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Acanthamoeba keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Prognosis for keratoplasty in Acanthamoeba keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

Treatment of acanthamoeba keratitis with chlorhexidine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900481-0

7 January 2021

10.1016/S0161-6420(03)00481-0

Identifiers

DOI

1 reference

release_kqs7fb4msrashnfydirri7yyv4

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kqs7fb4msrashnfydirri7yyv4

24 November 2022

mapped directly with Wikidata item

1 reference